Bio
Dr. Shahram Hejazi is a medical device/life science executive with general management experience in both early-stage ventures and large global companies. As a Venture Partner with BioAdvance, he is responsible for investments in device, diagnostics and imaging field. Within the BioAdvance portfolio, Dr. Hejazi focuses on working with mid/late stage molecular imaging, life science tools and diagnostics companies. Previously, Dr. Hejazi was the President of Kodak's life science division (now called Carestream Molecular Imaging), where he had global responsibility for R&D, manufacturing, operations, sales, marketing and service. While holding this position, Dr. Hejazi led the system business to successful double-digit annual growth and directed the launch of a new imaging agent business. Before Kodak, he was the CEO of Zargis Medical Corporation (an early stage medical device company that spun-off from Siemens), where he led the company’s efforts in areas ranging from raising capital and technology development to completion of several clinical trials, FDA approval and product launch. Prior to Zargis, Dr. Hejazi was the Head of the Strategic Business Development group at Siemens, responsible for identifying early-stage growth/investment opportunities and new business development in the medical field. Earlier in his career, Dr. Hejazi held R&D management positions within the diagnostic imaging and nanotechnology fields at Kodak and IBM. Dr. Hejazi has authored over 10 scientific publications and has been interviewed by several professional journals on topics related to molecular imaging/diagnostics. He is an FDA Industry Advisory Panel Member for Molecular and Clinical Genetic Devices, an Advisory Board Member for Fox Chase Cancer Center, a Board Member for SibTech Incorporated, and a previous Board Member for Alpha Innotech Corporation (APNO). PhD in engineering with emphasis in biophysics and an executive business education at Stanford University.
